Company
HERON THERAPEUTICS, INC. /DE/
HRTX · CIK 0000818033
Acquisition (code M) of 13,797 shares; price not stated (see filing).
Reporting Person Collard Craig A · Officer Title Chief Executive Officer · Transaction Code M
Traded Oct 19, 2026 · Disclosed Oct 21, 2026
Source: SEC Form 4 · 0001193125-26-427524 · filed 2026-10-21 · View filing →
Disposition (code F) of 3,360 shares at $0.36 per share.
Reporting Person Collard Craig A · Officer Title Chief Executive Officer · Transaction Code F
Traded Oct 19, 2026 · Disclosed Oct 21, 2026
Source: SEC Form 4 · 0001193125-26-427524 · filed 2026-10-21 · View filing →
Acquisition (code M) of 3,874 shares; price not stated (see filing).
Reporting Person Forbes William P · Officer Title EVP, Chief Development Officer · Transaction Code M
Traded Oct 19, 2026 · Disclosed Oct 21, 2026
Source: SEC Form 4 · 0001193125-26-427542 · filed 2026-10-21 · View filing →
Disposition (code F) of 1,102 shares at $0.36 per share.
Reporting Person Forbes William P · Officer Title EVP, Chief Development Officer · Transaction Code F
Traded Oct 19, 2026 · Disclosed Oct 21, 2026
Source: SEC Form 4 · 0001193125-26-427542 · filed 2026-10-21 · View filing →
Acquisition (code M) of 3,874 shares; price not stated (see filing).
Reporting Person Duarte Ira · Officer Title EVP, Chief Financial Officer · Transaction Code M
Traded Oct 19, 2026 · Disclosed Oct 21, 2026
Source: SEC Form 4 · 0001193125-26-427545 · filed 2026-10-21 · View filing →
Disposition (code F) of 1,102 shares at $0.36 per share.
Reporting Person Duarte Ira · Officer Title EVP, Chief Financial Officer · Transaction Code F
Traded Oct 19, 2026 · Disclosed Oct 21, 2026
Source: SEC Form 4 · 0001193125-26-427545 · filed 2026-10-21 · View filing →